Salt Fund Gene Therapy, LP
Salt Fund · adviser of record: Salt Fund Management LLC · 2022 vintage
Salt Fund Gene Therapy, LP is a 2022 venture fund managed by Salt Fund, with $14.2mm raised (Form D, amount sold). It reported $16.4mm in gross assets at year-end 2025, 1.16x its size, its highest reported value.
- Latest value held
- $16.4mm year-end 2025
- Peak
- $16.4mm year-end 2025
- Fund size
- $14.2mm Form D, amount sold
- Held vs. size
- 1.16x peak 1.16x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $16.4mm | 1.16x | +25% over 2 yrs |
| 2023 | $13.2mm | 0.93x | +0% |
| 2022 | $13.2mm | 0.93x | – |
Other funds from Salt Fund
- Kyber Capital Crypto Fund I LP 2022
- Salt Fund LP - Series Food 2021
- Salt Fund LP - Series Longevity 2021
- Salt Fund I, L.P. 2020
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-3225912327. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.